• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从分娩到左心室辅助装置:一例围产期心肌病病例报告。

From labor and delivery to left ventricular assist device: A peripartum cardiomyopathy case report.

机构信息

Coastal Heart Center, New Hanover Regional Medical Center, 2131 S. 17th Street, P.O. Box 9000, Wilmington, NC 28402-9000, United States.

出版信息

Heart Lung. 2020 Jan-Feb;49(1):54-57. doi: 10.1016/j.hrtlng.2019.06.005. Epub 2019 Jul 10.

DOI:10.1016/j.hrtlng.2019.06.005
PMID:31301867
Abstract

OBJECTIVE

To report a peripartum cardiomyopathy (PPCM) case resulting in the implantation of a permanent left ventricular assist device (LVAD) as destination therapy.

METHOD

Electronic medical record and literature review surrounding PPCM.

RESULTS

A 39-year-old African America female of 38 weeks gestation presented to labor and delivery triage complaining of lower extremity edema and shortness of breath. Evaluation yielded an ejection fraction of 20-25% with left ventricular dilation, cardiomegaly, and interstitial edema. Following delivery, the patient experienced respiratory distress and was transferred to the cardiac intensive care unit (CICU) where she was stabilized and discharged. Within four weeks, the patient experienced sudden cardiac arrest requiring intubation, induced hypothermic treatment, and intravenous vasopressor and inotrope support. The patient was transferred out of CICU and discharged home with close outpatient follow-up in the heart failure clinic before urgently receiving a LVAD.

CONCLUSION

PPCM is a life-threatening and life-changing condition requiring highly specialized interdisciplinary care.

摘要

目的

报告一例围产期心肌病(PPCM)病例,该病例最终植入永久性左心室辅助装置(LVAD)作为终末期治疗。

方法

对 PPCM 的电子病历和文献进行回顾。

结果

一名 39 岁的非洲裔美国女性,38 孕周,因下肢水肿和呼吸困难就诊于分娩前护理分诊处。评估结果显示射血分数为 20-25%,伴有左心室扩张、心脏增大和间质水肿。分娩后,患者出现呼吸窘迫,被转至心脏重症监护病房(CICU),在那里她得到了稳定并出院。四周内,患者突发心脏骤停,需要插管、诱导低温治疗、静脉血管加压素和正性肌力支持。患者从 CICU 转出并出院回家,在心力衰竭门诊接受密切的门诊随访,随后紧急接受了 LVAD 治疗。

结论

PPCM 是一种危及生命且改变生活的疾病,需要高度专业化的多学科护理。

相似文献

1
From labor and delivery to left ventricular assist device: A peripartum cardiomyopathy case report.从分娩到左心室辅助装置:一例围产期心肌病病例报告。
Heart Lung. 2020 Jan-Feb;49(1):54-57. doi: 10.1016/j.hrtlng.2019.06.005. Epub 2019 Jul 10.
2
The outcome of patients with peripartum cardiomyopathy and consecutive implantation of a left ventricular assist device.围生期心肌病患者的结局及随后植入左心室辅助装置的情况。
J Card Surg. 2021 Aug;36(8):2651-2657. doi: 10.1111/jocs.15598. Epub 2021 May 7.
3
Guyton perspective in managing peripartum cardiomyopathy patient with pulmonary edema: a case report.Guyton 观点在围生期心肌病伴肺水肿患者管理中的应用:病例报告。
J Med Case Rep. 2024 Feb 12;18(1):87. doi: 10.1186/s13256-024-04398-2.
4
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.围生期心肌病的病理生理学、诊断和治疗:欧洲心脏病学会心力衰竭协会围生期心肌病研究组的立场声明。
Eur J Heart Fail. 2019 Jul;21(7):827-843. doi: 10.1002/ejhf.1493. Epub 2019 Jun 27.
5
Pregnancy-Associated Heart Failure: A Comparison of Clinical Presentation and Outcome between Hypertensive Heart Failure of Pregnancy and Idiopathic Peripartum Cardiomyopathy.妊娠相关心力衰竭:妊娠高血压性心力衰竭与特发性围产期心肌病的临床表现及结局比较
PLoS One. 2015 Aug 7;10(8):e0133466. doi: 10.1371/journal.pone.0133466. eCollection 2015.
6
Use of Impella heart pump for management of women with peripartum cardiogenic shock.使用 Impella 心脏泵治疗围产期心源性休克的女性。
Clin Cardiol. 2019 Oct;42(10):974-981. doi: 10.1002/clc.23249. Epub 2019 Aug 22.
7
Peripartum Serial Echocardiographic Findings in a Patient with Life-threatening Peripartum Cardiomyopathy.一名患有危及生命的围产期心肌病患者的围产期系列超声心动图检查结果
Intern Med. 2018 Nov 1;57(21):3105-3109. doi: 10.2169/internalmedicine.0748-17. Epub 2018 Jun 6.
8
Safe and Effective Use of Pharmacologic and Device Therapy for Peripartum Cardiomyopathy.围产期心肌病药物和器械治疗的安全有效应用。
Pharmacotherapy. 2016 Sep;36(9):955-70. doi: 10.1002/phar.1795. Epub 2016 Jul 29.
9
Massive respiratory dysfunction as sign of fulminant peripartum cardiomyopathy (PPCM).严重呼吸功能障碍作为暴发性围产期心肌病(PPCM)的体征。
Hypertens Pregnancy. 2012;31(4):451-3. doi: 10.3109/10641955.2012.679014.
10
Clinical characteristics and long-term outcomes in patients with peripartum cardiomyopathy (PPCM) receiving left ventricular assist devices (LVAD).接受左心室辅助装置(LVAD)治疗的围产期心肌病(PPCM)患者的临床特征及长期预后
Artif Organs. 2023 Feb;47(2):417-424. doi: 10.1111/aor.14406. Epub 2022 Sep 27.

引用本文的文献

1
Peripartum Cardiogenic Shock and Mechanical Circulatory Support.围产期心源性休克与机械循环支持
Interv Cardiol. 2023 Nov 29;18:e28. doi: 10.15420/icr.2020.09. eCollection 2023.
2
Cardiovascular adverse events in pregnancy: A global perspective.妊娠期心血管不良事件:全球视角
Glob Cardiol Sci Pract. 2021 Apr 30;2021(1):e202105. doi: 10.21542/gcsp.2021.5.